These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32321521)

  • 41. Moroccan National Immunization Technical Advisory Group: a valuable asset for the national immunization program and the immunization agenda in the EMRO region.
    Jroundi I; Benazzouz M; Yahyane AH; Alaoui MT; El Omeiri N
    Hum Vaccin Immunother; 2021 Aug; 17(8):2788-2792. PubMed ID: 33989118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics and practices of National Immunisation Technical Advisory Groups in Europe and potential for collaboration, April 2014.
    Takla A; Wichmann O; Carrillo-Santisteve P; Cotter S; Levy-Bruhl D; Paradowska-Stankiewicz I; Valentiner-Branth P; D'Ancona F;
    Euro Surveill; 2015 Mar; 20(9):. PubMed ID: 25764188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Canada's National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic.
    Tunis M; Deeks S; Harrison R; Quach C; Ismail S; Salvadori M; Warshawsky B; Young K; Mauviel C; Henry E
    Vaccine; 2023 Oct; 41(44):6538-6547. PubMed ID: 37658002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.
    Jauregui B; Janusz CB; Clark AD; Sinha A; Garcia AG; Resch S; Toscano CM; Sanderson C; Andrus JK
    Vaccine; 2015 May; 33 Suppl 1():A21-7. PubMed ID: 25919164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).
    Dawa J; Chaves SS; Ba Nguz A; Kalani R; Anyango E; Mutie D; Muthoka P; Tabu C; Maritim M; Amukoye E; Were F;
    Vaccine; 2019 Jan; 37(3):464-472. PubMed ID: 30502070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A systematic review of national immunization policy making processes.
    Bryson M; Duclos P; Jolly A; Bryson J
    Vaccine; 2010 Apr; 28 Suppl 1():A6-12. PubMed ID: 20413000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships.
    Bresee JS; Lafond KE; McCarron M; Azziz-Baumgartner E; Chu SY; Ebama M; Hinman AR; Xeuatvongsa A; Bino S; Richardson D; Porter RM; Moen A; McKinlay M;
    Vaccine; 2019 Aug; 37(35):5089-5095. PubMed ID: 31288998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.
    Donadel M; Panero MS; Ametewee L; Shefer AM
    Vaccine; 2021 Apr; 39(14):1897-1909. PubMed ID: 33750592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overlapping topics in advisory reports issued by five well-established European National Immunization Technical Advisory Groups from 2011 to 2014.
    Nijsten D; Houweling H; Durupt A; Adjagba A
    Vaccine; 2016 Dec; 34(50):6200-6208. PubMed ID: 27836436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction.
    Shen AK; Weiss JM; Andrus JK; Pecenka C; Atherly D; Taylor K; McQuestion M
    Health Aff (Millwood); 2016 Feb; 35(2):272-6. PubMed ID: 26858380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The NITAG Resource Centre (NRC): One-stop shop towards a collaborative platform.
    Adjagba A; Henaff L; Duclos P
    Vaccine; 2015 Aug; 33(36):4365-7. PubMed ID: 26165917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of existing systematic reviews for the development of evidence-based vaccination recommendations: Guidance from the SYSVAC expert panel.
    Pilic A; Reda S; Jo CL; Burchett H; Bastías M; Campbell P; Gamage D; Henaff L; Kagina B; Külper-Schiek W; Lunny C; Marti M; Muloiwa R; Pieper D; Thomas J; Tunis MC; Younger Z; Wichmann O; Harder T
    Vaccine; 2023 Mar; 41(12):1968-1978. PubMed ID: 36804216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving the quality and use of immunization and surveillance data: Summary report of the Working Group of the Strategic Advisory Group of Experts on Immunization.
    Scobie HM; Edelstein M; Nicol E; Morice A; Rahimi N; MacDonald NE; Danovaro-Holliday CM; Jawad J;
    Vaccine; 2020 Oct; 38(46):7183-7197. PubMed ID: 32950304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. National vaccination policies for health workers - A cross-sectional global overview.
    Young S; Goldin S; Dumolard L; Shendale S; McMurren B; Maltezou HC; Desai S
    Vaccine; 2024 Feb; 42(4):757-769. PubMed ID: 37321897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The new Italian National Immunization Technical Advisory Group (NITAG) and its commitment to endorse a new efficient National Immunization Plan in COVID-19 times.
    Silenzi A; Siddu A; D'Amelio AC; Cataldi S; Fasano C; Maraglino F; Rezza G; Signorelli C
    Ann Ist Super Sanita; 2023; 59(1):26-30. PubMed ID: 36974701
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.